Baby formula and food company Bubs Australia (ASX: BUB) spent a large part of FY23 undertaking reputation management as its dirty laundry was hung for the world to see. Boardroom disputes, miffed shareholders, lawsuits, and a CEO ousting—the Company had to work in overdrive to maintain shareholder confidence. The impact of its decisions can be
Read MoreJust a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business, the baby milk formula company announced another shake up of its executive line up. Perhaps a foreseeable one, this time founder and CEO Kristy Carr was terminated from her position with immediate effect due to
Read MoreThe FDA has deferred further consideration of one of Australia’s top dairy producers A2 Milk’s (ASX: A2M) request to import infant milk formula (IMF) into the United States. Though the application has not been rejected, it is also not close to being approved. Since February 2022, the US has been facing an acute shortage of
Read MoreIt’s hard to believe that in 2022 food security in America would be an issue, but for thousands of parents, feeding their babies is a daily struggle. The US baby formula crisis was the perfect storm of a monopolised market, a serious food recall and a sloppy government response. The story in a nutshell? Major
Read MoreIt’s the most talked about stock in the retail investor community right now, and having climbed 61.84% in the past month it may be for a while yet. I’m talking about Bubs (ASX: BUB), the company coming to the rescue of US parents who are the unfortunate victims of the US formula crisis. The serious
Read MoreI’m convinced the commodities index should include companies that manufacture toilet rolls and now, baby formula. Seemingly rarer than hen’s teeth, the powder gold is causing major headaches for parents across the US. The limited supply isn’t solely due to COVID related logistics issues, but rather the result of a sluggish government response and wider
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.